F.I.S. - FABBRICA ITALIANA SINTETICI S.p.A.
FIS is a private Italian company that has been at the forefront of API production since its establishment in 1957.
Specializing in Custom Synthesis, FIS exclusively produces intermediates, advanced intermediates, and APIs for pharmaceutical companies, allowing them to own the NDA. The company offers a comprehensive range of integrated services, including process research and development, optimization, and scale-up facilities to support validation and commercial launch.
In addition to Custom Synthesis, FIS also develops and markets a diverse portfolio of Generic APIs, spanning anxiolytics, anticonvulsants, antidepressants, analgesics, anti-inflammatory agents, antibacterials, antifungals, cardiovascular drugs, and diuretics.
Headquartered in Italy, FIS operates within the Industrial and Manufacturing sectors, positioning itself as a key player in the pharmaceutical manufacturing landscape.
Although specific details about the company's last investment and investors are currently unavailable, FIS continues to solidify its position as a leader in API production within the pharmaceutical industry.
There is no investment information
No recent news or press coverage available for F.I.S. - FABBRICA ITALIANA SINTETICI S.p.A..